To study the safety and efficacy of fluoroscopic removal of self-expandable metallic stent for airway stenosis.
Introduction
Airway stenosis is a potentially life-threatening condition, which may be caused by tumor invasion or benign diseases, such as, endotracheal intubation injury, endobronchial tuberculosis, and thoracic trauma. Most of these patients may be too sick to undergo definitive open surgery or may not be willing to undergo surgery under general anesthesia. [1] Conservative treatment simply assists in alleviation of airway symptom, but show no curative effect on airway stenosis. Since first adoption of metal stents to treat bronchial obstruction, the airway stent has become an effective method for airway stenosis [2] [3] [4] [5] and has been widely used in clinical practice. Complications of airway stent include stent restenosis caused by tumor or granulation tissue, stent fracture, and stent migration. [6] Stent removal may become necessary if these complications result in airway obstruction or injury. Endoscopic removal of airway stent has been reported in small series. [7, 8] However, few studies have described the techniques and complications of fluoroscopic removal of airway stent. The safety and efficacy of fluoroscopic stent removal and the optimal safe duration of stent implantation have not been determined. We report clinical results in fluoroscopic removal of airway stents for airway stenosis over a 6-year period.
Materials and methods

Patients
This study was approved by the Ethics Committee and Medical Records Management Section of our university. The written informed consents were obtained from all patients or their parents if the patients are less than 18 years old. We conducted a retrospective analysis of 67 patients who underwent fluoroscopic stent removal due to patient's refusal of surgery and general anesthesia from March 2011 to April 2017. All the patients were enrolled after chest computed tomography (CT) examination. The inclusion criteria included all patients with benign airway stenosis, and dyspnea had been significantly alleviated and needed planned removal. Following doctor's advice, they admitted to hospital for stents removal to avoid long-term complications, with no obvious symptom or sign (planned removal). Patients show complications after stenting such as intolerance of stenting, stent migration, excessive tissue hyperplasia, inadequate expansion and deformation, and strut fracture. New airway stents are needed to replace the original stents, such as bare stents placed under emergency situation will be removed and the covered airway stents will be replaced when the patient's condition is stable. The exclusion criteria included patients with advanced malignant tumors with a survival time of less than 3 months and no obvious stent complications; patients with severe visceral dysfunction who unable to withstand the stent removal procedure; patients refused to remove the stent ( Fig.1 ).
Technical details of fluoroscopic removal
All patients underwent chest CT scans with/without bronchoscopy before stent removal ( Fig. 2 ). Under conscious situation, balloon dilatation of airway stent was performed immediately after stenting due to insufficient expansion (n = 11) and before stent implantation or removal due to severe airway stenosis (n = 24). All self-expandable metal airway stents were designed and manufactured by Micro-Tech Co Ltd (Nanjing, China). Airway metal stent was woven with a temperature-memory nickeltitanium alloy wire, which was visible on fluoroscopy. In an emergency, we placed 6 bare stents to immediately relieve severe dyspnea and avoid asphyxia. Seventy covered stents were used in nonemergency situations. All airway stents were removed transorally under fluoroscopy and local anesthesia via lidocaine. Bronchoscopy was not performed during the removal, which might use after the operation if removal failed. The patient took the supine position and the head was faced toward the operator to prevent asphyxiation. A 5F vertebral artery catheter (Cook Corporation, Bloomington, IN) was advanced along a 0.035 inch stiff hydrophilic guide wire (Cook Corporation), then 2% lidocaine was injected through vertebral artery catheter for topical anesthesia. A 10-14F long sheath was inserted via the stiff hydrophilic guide wire, and an extractive hook was then inserted. The tip of hook was placed next to the airway stent to withdraw the airway stent ( Fig. 3 ). The sputum aspiration tube was advanced for maintaining airway patency and sputum drainage.
Complications of stent removal and follow up
All complications were scored and analyzed. Patients were followed up once a month within 3 months after stent placement, and every 2 months thereafter. If symptoms flared as needed, patients were asked to admit to hospital at any time. All patients underwent chest CT scans after stent placement, and bronchoscopy was used for some patients if necessary. Telephone follow up was used for patients did not admit to hospital.
Statistical analysis
Data were expressed as mean ± standard error and analyzed using Student t test and analysis of variance. Qualitative data were expressed as the percentage, and analyzed by Fisher exact test. Patency rate was compared using the Log-rank (Mantel-Cox) Test (GraphPad Software, Inc San Diego, USA). Statistical significance was considered when P < .05.
Results
The patients' characteristics
The 67 patients, 39 male and 28 female, ranged in age from 12 to 85 years, with a mean age of 51.1 ± 2.2 years. Seventy-six airway stents were implanted in 67 consecutive patients over a 6-year period, of which, 9 patients underwent second stent implantation after removal. The mean procedure time for stent implantation Figure 3 . Fluoroscopic treatments for airway stenosis with airway stents. Pre-dilation of severe stenosis caused by tracheotomy with a balloon (A), and then a straight airway stent was implanted (B). A long sheath was inserted via the stiff hydrophilic guide wire, and an extractive hook was then inserted, with the tip of hook was placed next to the airway stent (C). Airway stent was withdrawn successfully by extractive hook (D). Sixteen Y-shaped airway stents were placed in the trachea and bilateral main bronchi. A total of 55 tubular stents were placed in the middle and upper trachea (n = 47), the middle trachea (n = 4), and the middle and lower trachea (n = 4). Two L-shaped airway stents were placed in the trachea and left main bronchus. Their stents were placed in trachea-right main bronchus, right main bronchus and left main bronchus. Before stent placement, 66 patients had dyspnea in varying degrees, including 16 patients with cough and expectoration, and 2 patients with hemoptysis. Dyspnea classification was 3.6 ± 0.7 before stent placement according to the American Thoracic Association Dyspnea Classification Standard, which decreased significantly to 0.6 ± 1.4 after stent placement and dyspnea symptoms were significantly alleviated.
Indications for stent removal
The indications for stent removal were shown in Table 2 , which included planned removal (n = 40), excessive granulation tissue (n = 15), intolerance of stenting (n = 6), inadequate expansion and deformation (n = 5), stent migration (n = 5), replacement of bare stent (n = 4), and strut fracture (n = 1). Six bare stents were emergency implanted for severe airway stenosis, of which, 3 stents were removed and replaced by covered stents, with a mean duration of 8.7 ± 3.2 days, and 1 stent was replaced by tracheal T tube. The remained 2 patients refused to replace the bare stents with covered stents, and the bare stents were removed due to severe stenosis after more than 3 months. Stent migration, intolerance of stenting, and inadequate expansion and deformation were the main indications for early stent removal. Excessive granulation tissue was the most common indication for later stent removal, with a mean duration of 89.9 ± 15.0 days. One case underwent stent removal due to strut fracture 105 days after stenting.
Complications of stent removal
As shown in Table 3 , 74 of 76 airway stents were successfully removed from 67 consecutive patients, 5 stents showed strut fracture, only 2 stent showed retained struts after removal, for a technical success rate of 97.4% (74/76). Before stent removal, 29 patients had dyspnea in varying degrees, including 6 patients with cough and expectoration. Dyspnea classification was 1.4 ± 1.7 before stent removal, which decreased significantly to 0.8 ± 0.9 after stent removal and dyspnea symptoms were significantly alleviated.
Two patients died of complications (1 hemorrhage and 1 respiratory failure), resulting in a clinical success rate of 94.7% (72/76) and 30-day mortality of 2.6%. The 3 retained stent pieces were successfully removed by endoscope; the remaining 71 stents were removed in 1 piece. There were 17 complications of stent removal: death from massive bleeding (n = 1), restenosis requires stenting (n = 9), strut fracture and retained stent pieces (n = 5), and dyspnea requires mechanical ventilation (n = 2).
The most common complications were restenosis caused by excessive granulation tissue and strut fracture, after a mean duration of 93.3 ± 14.5 days ( Fig. 4 and Table 4 ). A 52-year male patient developed airway stenosis and esophageal airway fistula after resection of esophageal carcinoma, a Y type airway stent was implanted but had to remove immediately due to intolerance of stent. This patient died of spontaneous massive hemoptysis might cause by esophageal airway fistula 3 days after stent removal. In most of patients, mild hemoptysis was found, without need for medication. During stent removal, 4 patients showed dyspnea with decreased pulse oxygen, and 2 cases needed mechanical ventilation. The symptoms were relieved in 1 patient and then endotracheal tube was removed within 4 hours. A 43year female patient with relapsing polychondritis showed bad respiratory condition before stent placement, the opening of the left upper lobe bronchus is partially blocked by the left branch of the second Y type stent. She died of respiratory failure 2 days after stent implant.
Second stenting after removal and follow up
As shown in Table 4 , 20 airway stents, 15 straight airway stents, and 5 Y type airway stents, were implanted again after removal for replacement of bare stents (n = 4), or due to restenosis (n = 9), migration (n = 3), inadequate expansion (n = 3), and intolerance (n = 2). Chest CT and bronchoscopy were performed during postremoval admission to prevent long-term compilation. During follow up, 1 patient died of respiratory failure 1 month after removal, and 2 patients died of tumor progression 42 days and 6 months after removal. Two patients underwent tracheotomy and tracheal T tube implantation 1 to 2 years after stent removal. Survival rate follow up. The survival rates were 83.8%, 82.1%, and 82.1% for 0.5, 3, and 6 years ( Fig. 5 ).
Discussion
The airway stent has become an effective method for the treatment of airway stenosis, [2] [3] [4] [5] and has been widely used in clinical practice. However, long term implantation of airway stents may cause several complications, such as, strut fracture, stent migration, and excessive granulation hyperplasia. Stent removal is necessary to avoid these complications. [9] At present, endoscopic removal of airway stent has been reported in small series, [7, 8] which often performed under general anesthesia [10] [11] [12] [13] [14] or local anesthesia in a few reports. [15, 16] Fluoroscopic removal of airway stent is rarely reported for airway stenosis. In this study, 74 of 76 airway stents were successfully removed, with a technical success rate of 97.4%. Compared with stent removal with rigid alligator forceps, in which 73% of stents were removed piecemeal. [10] In our study, only 2 stent showed retained struts after removal and 3 retained stent pieces were successfully removed by endoscope, the remaining 71 stents were removed in 1 piece. Our data indicate that fluoroscopic removal of airway stents is effective and feasible for airway stenosis. The details provided in previous reports varied widely and almost with no detailed discussions in complications. Our study is the few study to report techniques and complications of fluoroscopic removal of airway stents. Although the process of fluoroscopic removal is quite short in our study (less than 30 minutes), there are also risks during removal. These serious complications include bleeding, tissue laceration, airway obstruction, and even death. [10, 17, 18] In our study, there were 2 deaths, 1 patient of airway stenosis and esophageal airway fistula died of massive hemoptysis 3 days after stent removal; the other patient of relapsing polychondritis died of respiratory failure 2 days after stent implant. The 2 patients might die of etiology rather than stenting procedure. In addition, the total incidence of complications was 23.0% (17/74), similar as that previously reported by using of bronchoscope. [10, 11, 16, 17] Excessive granulation tissue may cause difficulty or failure of removal. [15] As indwelling time increase, the incidence of granulation tissue hyperplasia and stent fracture increase. [19] [20] [21] The endothelialization appear 2 months after stenting, [18] stents are difficult to be removed after 10 months. [10] So, 6 months [22] or earlier [23] is regarded as the optimal indwelling time for removal. However, the most suitable indwelling time for airway stenosis is still inconclusive. In our study, stents are recommended for removal within 3 months to avoid excessive granulation tissue. Silicon stents are more suitable for patients with benign disorders caused airway obstruction, especially young and little patients. Patients received stent placement of metallic stents rather than silicon stent to relieve dyspnea caused by severe airway stenosis due to their refusal of surgery and general anesthesia. In this study, covered stents were used for these patients to avoid excessive tissue growth into stent, and for the convenience of removing the stent. Radiologic placement and removal of metallic stents are suitable for old patients with an age more than 70; patient with severe co-morbidities; or patient's refusal of surgery and general anesthesia.
Securing the airway is a major step and first step and priority in any interventional bronchology procedure. The placement or removal of the stent under general anesthesia appears to be safer than under local anesthesia in patients with airway stenosis. However, according to our clinical experience, patients with severe airway stenosis are at high risk for endotracheal intubation and anesthesia. In our center, emergency endotracheal intubation can be performed under fluoroscopy guidance and local anesthesia for patients with acute dyspnea or asphyxia. Besides, vocal cords are the narrowest part in airway and a stent can injure or even completely block the airway at vocal cords during stent removal procedure. According to our experience, the tip of hook was placed next to the airway stent and captured the stent firmly throughout the whole procedure of removal to avoid the drop of stent and life threatening complication of airway block. The stent should be pulling out slowly and carefully to minimize the injury to vocal cords and tracheal.
There are several limitations of the study. The pathological changes and optimal removal duration of stent after placement need confirm in further animal study. In addition, surgical placement and removal of the metallic stents under general anesthesia with rigid bronchoscope remain gold standard and airway stents removal often requires a variety of technologies, [24] we removed stent solely under radiology guidance.
Conclusions
Fluoroscopic removal of airway stent is technically feasible and effective. Stents are recommended for removal within 3 months for treating airway stenosis to avoid complications such as excessive granulation tissue formation in stent.
